![Timothy P. Coleman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Timothy P. Coleman
Gründer bei
Nemucore Medical Innovations, Inc.
Profil
Timothy P.
Coleman is the founder of Nemucore Medical Innovations, Inc. (founded in 2008) where he currently holds the title of President, CEO, Treasurer & Director.
Dr. Coleman is also the founder of Biocache Pharmaceuticals, Inc...
Dr. Coleman's former job includes being the Head-Biomedical Strategy Group at PricewaterhouseCoopers LLP.
Aktive Positionen von Timothy P. Coleman
| Unternehmen | Position | Beginn |
|---|---|---|
Nemucore Medical Innovations, Inc.
 Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes life saving nanomedicines for the treatment of MDR cancers | Gründer | 01.01.2008 |
Ehemalige bekannte Positionen von Timothy P. Coleman
| Unternehmen | Position | Ende |
|---|---|---|
Biocache Pharmaceuticals, Inc. | Gründer | - |
PricewaterhouseCoopers LLP
 PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Corporate Officer/Principal | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
8
Beziehungen ersten Grades
3
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
PricewaterhouseCoopers LLP
PricewaterhouseCoopers LLP Miscellaneous Commercial ServicesCommercial Services Provides auditing, assurance, consulting and tax & business consulting services | Commercial Services |
Biocache Pharmaceuticals, Inc. | |
Nemucore Medical Innovations, Inc.
Nemucore Medical Innovations, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes life saving nanomedicines for the treatment of MDR cancers | Health Technology |
